Modification of Rhythmic Risk Assessment by Ventricular Tachycardia Ablation
2 other identifiers
observational
30
1 country
1
Brief Summary
Sudden cardiac death is a frequent cause of cardiovascular mortality. Numerous rhythmic risk assessment criterion have been described targeting the substratum, the cardiac nervous tone or the trigger of arrhythmias. Development of ventricular tachycardia ablation in the past few years show interesting results preventing the recurrence of ventricular arrhythmias.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 27, 2017
CompletedStudy Start
First participant enrolled
September 9, 2017
CompletedFirst Posted
Study publicly available on registry
March 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2019
CompletedJuly 11, 2018
July 1, 2018
12 months
July 27, 2017
July 10, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
measure assessing change before and after Ventricular Tachycardia Ablation of the non-invasive parameters analysis of the rhythmic risk before and after Ventricular Tachycardia Ablation
non invasive parameters analysis of the rhythmic risk will be evaluated by the evaluation of the T wave alternans
10 minutes and 60 minutes after the Ventricular Tachycardia Ablation
Secondary Outcomes (2)
Assessing the correlations of the modifications of the risk criterion after ablation with the recurrences of arrhythmias at one year follow-up
3 months, 6 months and 12 months after the Ventricular Tachycardia Ablation
Study of the correlation between the modifications of non-invasive parameters analysis of the rhythmic risk and the success of the ablation procedure
3 months, 6 months and 12 months after the Ventricular Tachycardia Ablation
Interventions
The usual organization of hospitalization of the patients addressed for ventricular tachycardia ablation and his follow-up are not modified by the protocol. .
Eligibility Criteria
people wich an Ventricular Tachycardia Ablation necessary and programed
You may qualify if:
- Patients undergoing ventricular tachycardia,
- patients with ischemic cardiomyopathy according to European Society of Cardiology Guidelines,
- patients with implanted cardiac defibrillator.
You may not qualify if:
- Contra-indication to stress test,
- permanent atrial fibrillation,
- permanent ventricular pacing,
- left bundle block.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital of Toulouse
Toulouse, 31000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Philippe MAURY, MD
University Hospital of Toulouse
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 27, 2017
First Posted
March 5, 2018
Study Start
September 9, 2017
Primary Completion
September 1, 2018
Study Completion
February 1, 2019
Last Updated
July 11, 2018
Record last verified: 2018-07